Emtricitabine
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='95/959998/Cv/ | + | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='95/959998/Cv/2'> |
Emtricitabine (commonly called FTC, systematic name 2',3'-dideoxy-5-fluoro-3'-thiacytidine[1]), with trade name Emtriva (formerly Coviracil), is a nucleoside reverse-transcriptase inhibitor (NRTI) for the prevention and treatment of HIV infection in adults and children. See also [https://en.wikipedia.org/wiki/Emtricitabine]. | Emtricitabine (commonly called FTC, systematic name 2',3'-dideoxy-5-fluoro-3'-thiacytidine[1]), with trade name Emtriva (formerly Coviracil), is a nucleoside reverse-transcriptase inhibitor (NRTI) for the prevention and treatment of HIV infection in adults and children. See also [https://en.wikipedia.org/wiki/Emtricitabine]. | ||
Revision as of 10:56, 29 March 2023
| |||||||||||
